Results 251 to 260 of about 6,836,441 (345)
Microglia (BV2) and IL‐4‐treated BMDMs promote astrocytoma clustering and inhibit tumor growth, not shown in other macrophage cells. In vivo, microglial co‐implantation enhances CD8+ T cell infiltration, elevates Granzyme B, lowers circulating MDSCs, and extends survival only in immune‐competent mice, but not in immune‐deficient mice.
Tzu‐Chieh Sun+5 more
wiley +1 more source
Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes. [PDF]
Trněný M+18 more
europepmc +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts+8 more
wiley +1 more source
Patient reported outcomes in the FDA approved drugs for systemic rheumatic diseases (2013-2024). [PDF]
Xie Y+5 more
europepmc +1 more source
Incorporating Patient-Reported Outcomes Into Health Care To Engage Patients And Enhance Care.
D. Lavallee+6 more
semanticscholar +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira+14 more
wiley +1 more source
Patient-reported outcomes with subcutaneous immunoglobulin in secondary immunodeficiency. [PDF]
Cowan J+4 more
europepmc +1 more source
D. Barocas+17 more
semanticscholar +1 more source